Because it was reported that SCARA5 and AOX1 had a negative impact on cancer cell malignancy and tumor growth, improved the efficacy of anticancer drugs and were epigenetically regulated in cancer, we decided to concentrate on these genes, to evaluate whether CM-272-induced expression would participate in the cytotoxic effect of this drug. The gene discussed is SCARA5; the disease is cancer.